A Danish Study to Assess the Efficacy of Implantable Cardioverter Defibrillator in Patients with Coronary Artery Disease Resuscitated from Ventricular Fibrillation Who Receive Complete Revascularization
| Registry | NCT04576130, acronym DanICD |
|---|---|
| Status | Recruiting |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: none, prevention |
| Enrollment | 1200 (Estimated) |
| Sponsor | Copenhagen University Hospital, Rigshospitalet (Other) |
| Conditions | Coronary Artery Disease, Acute Myocardial Infarction, Ventricular Fibrillation, Ventricular Tachycardia, Sustained, Out-Of-Hospital Cardiac Arrest |
| Interventions | Implantable cardioverter defibrillator (Device) |
| Dates | start 2020-10-12, primary completion 2032-10-01 (estimated), completion 2032-10-01 (estimated), first posted 2020-10-06, last updated 2025-01-27 |
| Locations | 1 site in Denmark |
Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Coronary Artery Disease All trials for Acute Myocardial Infarction All trials of Implantable cardioverter defibrillator
DanICD is a randomized, controlled study to with the aim to assess whether there is a benefit of ICD-implantation in patients with coronary artery disease (including acute myocardial infarction), who survive cardiac arrest due to ventricular fibrillation/sustained ventricular tachycardia and undergo revascularization and with an LVEF above 35%.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| ICD-implantation | Experimental | Device: Implantable cardioverter defibrillator | Implantation of an ICD either during admission or within 4 weeks after discharge from index event. |
| Standard care | No intervention | Guideline directed medical therapy |
Sex: All, ages: 18 Years to any
Inclusion Criteria: * Patients with CAD and cardiac arrest due to VF/VT, where angiogram is performed with complete revascularization (PCI, CABG or hybrid coronary revascularization) before ICD implantation. Unfavorable artery for PCI (i.e., excessive vessel tortuosity or chronic total occlusion) or high-risk invasive treatment is not mandatory in order to achive complete revascularization. * Age ≥18 years * LVEF >35% at the time of discharge. The most recent LVEF assessment on which the current medical treatment will be based at the time of entry into the study will be used as baseline LVEF. Exclusion Criteria: * Non-ischemic cause of cardiac arrest (i.e. ion channel diseases, non-ischemic cardiomyopathy) * Previous CABG within the last 3 months before index hospitalization * Life expectancy less than 1 year or severe neurologic outcome * Unable or unwilling to give informed consent * Pregnancy
| Facility | City | Country | Status |
|---|---|---|---|
| Copenhagen University Hospital, Rigshospitalet | Copenhagen | Denmark | Recruiting |